April 25, 2024
Stocks & Bonds
[EQUITIES] ‘Dentium’s overseas revenue to rise on China plant’
[THE INVESTOR The overseas revenue of Dentium, which has the second-largest dental implant market share in Korea, will increase as its factory in China begins operations next year, said NH Investment and Securities on May 24.
 |
Upon government approval, its plant in Shanghai will begin to operate and with its capacity to produce dental devices worth 36 billion won a year its revenue will increase significantly, said analyst Goo Wan-seong.
The company has high operating profit ratio at 23.8 percent but its stock price is still undervalued, trading at 15 times its price-earnings ratio, compared to 26 times of market leader Austem, said the analyst.
By Hwang You-mee (glamazon@heraldcorp.com)
